Antimetabolites: all 7,305 studies that test it

Page 29 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast CancerCompletedNCT00191789Phase 2Results posted
• An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyCompletedNCT00191646Phase 3Results posted
• Instillation of Gemcitabine in Patients With Superficial Bladder CancerTerminatedNCT00191477Phase 3Results posted
• A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast CancerCompletedNCT00191451Phase 2Results posted
• Gemcitabine in Ovarian CancerCompletedNCT00191334Phase 2Results posted
• Molecular Profiling in Lung Cancer PatientsCompletedNCT00191308Phase 2Results posted
• Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane RegimenCompletedNCT00191269Phase 2Results posted
• To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00191191Phase 2Results posted
• A Phase III Trial For Patients With Metastatic Breast CancerCompletedNCT00191152Phase 3Results posted
• Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00191139Phase 2Results posted
• Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the CervixCompletedNCT00191100Phase 3Results posted
• A Trial for Patients With Advanced/Recurrent Cervical CancerCompletedNCT00190983Phase 2Results posted
• A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer PatientsCompletedNCT00190671Phase 1/2Results posted
• Natural Killer (NK) Cell Transplantation for AMLCompletedNCT00187096Not applicableResults posted
• Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00186875Phase 2Results posted
• Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic CancerCompletedNCT00185588Phase 1/2Results posted
• Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical CarcinomaCompletedNCT00184093Phase 1/2Results posted
• Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction CancerCompletedNCT00183898Phase 2Results posted
• Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior TherapyCompletedNCT00182000Phase 3Results posted
• Intravenous Allopurinol in Heart FailureCompletedNCT00181155Phase 2Results posted
• Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal CancerCompletedNCT00177307Phase 2Results posted
• A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus CancersTerminatedNCT00177255Phase 2Results posted
• Stem Cell Transplant for Bone Marrow Failure SyndromesCompletedNCT00176878Phase 2/3Results posted
• Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
• Stem Cell Transplant for HemoglobinopathyCompletedNCT00176852Phase 2/3Results posted
• CINJALL: Treatment for Children With Acute Lymphocytic LeukemiaCompletedNCT00176462Phase 2Results posted
• Stem Cell Transplantation for Fanconi AnemiaTerminatedNCT00167206Phase 1/2Results posted
• Post Transplant Donor Lymphocyte InfusionTerminatedNCT00167180Phase 2Results posted
• Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins LymphomaCompletedNCT00166439Phase 2Results posted
• Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium ThiosulfateTerminatedNCT00165503Phase 2Results posted
• Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic CancerCompletedNCT00161213Phase 2Results posted
• Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal CancerCompletedNCT00159432Phase 2Results posted
• Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)CompletedNCT00156013Phase 1/2Results posted
• Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment RegimensCompletedNCT00149214Phase 2Results posted
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck CancerCompletedNCT00148122Phase 2Results posted
• Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal CancerCompletedNCT00143403Phase 3Results posted
• Therapy for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00137111Phase 3Results posted
• Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or MyelodysplasiaCompletedNCT00136084Phase 3Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00134004Phase 2Results posted
• Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer PatientsCompletedNCT00130533Phase 3Results posted
• Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung CancerTerminatedNCT00129974Phase 2Results posted
• EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast CancerCompletedNCT00129935Phase 3Results posted
• Use of an Antibiotic as an Enhancer for the Treatment of Social PhobiaCompletedNCT00128401Phase 2Results posted
• D-cycloserine in the Management of Chronic Low Back PainCompletedNCT00125528Phase 2Results posted
• Stroke With Transfusions Changing to HydroxyureaTerminatedNCT00122980Phase 3Results posted
• Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)CompletedNCT00122460Phase 3Results posted
• Remission and Joint Damage Progression in Early Rheumatoid ArthritisCompletedNCT00122382Phase 3Results posted
• A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast CancerCompletedNCT00121836Phase 4Results posted
• Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney CancerCompletedNCT00121251Phase 1/2Results posted
• S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaTerminatedNCT00121186Phase 2Results posted
• Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00119392Phase 2Results posted
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT00119366Phase 2Results posted
• A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal CancerCompletedNCT00118755Phase 2Results posted
• Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2Results posted
• Azacitidine and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00118287Phase 1/2Results posted
• Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00117962Phase 2Results posted
• Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's LymphomaCompletedNCT00117156Phase 2Results posted
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal CancerCompletedNCT00114231Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine CancerCompletedNCT00114218Phase 2Results posted
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryTerminatedNCT00113399Phase 3Results posted
• Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine FailureTerminatedNCT00113321Phase 2Results posted
• Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal CancerCompletedNCT00113230Phase 2Results posted
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon CancerCompletedNCT00112918Phase 3Results posted
• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
• Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCompletedNCT00111761Phase 2Results posted
• ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00110084Phase 2Results posted
• S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's LymphomaCompletedNCT00109928Phase 2Results posted
• S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00109837Phase 2Results posted
• Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT00107315Phase 2Results posted
• S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast CancerCompletedNCT00107276Phase 2Results posted
• Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerCompletedNCT00106002Phase 2Results posted
• Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00104858Phase 2Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00103285Phase 3Results posted
• Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00102804Phase 3Results posted
• Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic SyndromesCompletedNCT00102687Phase 2Results posted
• Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced CancerTerminatedNCT00101907Phase 1Results posted
• Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00101283Phase 2Results posted
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNCT00100815Phase 2Results posted
• S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedNCT00100789Phase 2Results posted
• Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00098787Phase 2Results posted
• Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00098670Phase 2Results posted
• Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00096382Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesCompletedNCT00096135Not applicableResults posted
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid LeukemiaCompletedNCT00096122Phase 1/2Results posted
• Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00096018Phase 1/2Results posted
• Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)CompletedNCT00095875Phase 3Results posted
• Decitabine in Treating Patients With MyelofibrosisActive, not recruitingNCT00095784Phase 2Results posted
• Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung CancerCompletedNCT00095199Phase 3Results posted
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00093808Phase 2Results posted
• Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast CancerCompletedNCT00093795Phase 3Results posted
• Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity CancerCompletedNCT00093496Phase 2Results posted
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerCompletedNCT00093379Phase 2Results posted
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerTerminatedNCT00089128Phase 2Results posted
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerTerminatedNCT00089102Phase 2Results posted
• Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
• Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).CompletedNCT00088218Phase 2Results posted
• Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural MesotheliomaCompletedNCT00087698Phase 2Results posted
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerCompletedNCT00087178Phase 3Results posted
• S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast CancerCompletedNCT00087152Phase 2Results posted
• S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) JunctionCompletedNCT00086996Phase 2Results posted

← Antimetabolites overview